<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 1-10261
----------
DIALYSIS HOLDINGS, INC.
(formerly known as Vivra Incorporated)
-------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
1850 GATEWAY DRIVE, SUITE 500, SAN MATEO, CALIFORNIA 94404 (415) 577-5700
-------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
COMMON STOCK, PAR VALUE $0.01 PER SHARE
PREFERRED STOCK PURCHASE RIGHTS
-------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
NONE
-------------------------------------------------------------------------
(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) X Rule 12h-3(b)(1)(i) X
--- ---
Rule 12g-4(a)(1)(ii)___ Rule 12h-3(b)(1)(ii)___
Rule 12g-4(a)(2)(i) ___ Rule 12h-3(b)(2)(i) ___
Rule 12g-4(a)(2)(ii)___ Rule 12h-3(b)(2)(ii)___
Rule 15d-6 ___
Approximate number of holders of record as of the certification or notice
date: 1
--------
Pursuant to the requirements of the Securities Exchange Act of 1934 (NAME
OF REGISTRANT AS SPECIFIED IN CHARTER) has caused this certification/notice to
be signed on its behalf by the undersigned duly authorized person.
Date: JULY 2, 1997 By: /s/ Ralph Z. Levy, Jr.
------------ ------------------------
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the
General Rules and Regulations under the Securities Exchange Act of 1934. The
registrant shall file with the Commission three copies of Form 15, one of which
shall be manually signed. It may be signed by an officer of the registrant, by
counsel or by any other duly authorized person. The name and title of the
person signing the form shall be typed or printed under the signature.
